ad image

Q42023

1 / 2
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
CMC

Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform

Wheeler Bio

PAO-12-23-CL-04Feb 08, 2024
An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World
Decentralized Clinical Trials

An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World

Richie Pfeiffer

PPD, part of Thermo Fisher Scientific

PAO-12-23-CL-08Jan 17, 2024
Navigating HPLC Method Development: Tips for Success
Chromatography

Navigating HPLC Method Development: Tips for Success

Ransom Jones

Mikart

PAO-12-23-CL-09Jan 17, 2024
Technological Innovations Enhancing Downstream Productivity and Their Critical Process Parameters for Real-Time Control
Downstream Processing

Technological Innovations Enhancing Downstream Productivity and Their Critical Process Parameters for Real-Time Control

Giovanni Campolongo

Hamilton

PAO-12-23-CL-07Jan 04, 2024
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

PAO-12-23-RT-01Dec 14, 2023
Pioneering Breakthroughs in Retinal Disease Treatment
Retinal Disease

Pioneering Breakthroughs in Retinal Disease Treatment

David Alvaro, Ph.D.; David Zacks, M.D., Ph.D.; David Esposito

Pharma's Almanac

PAO-12-23-CL-01Dec 14, 2023
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

PAO-12-23-CL-06Dec 14, 2023
Rethinking Cell Engineering for Cell Therapy Manufacturing
Cell Therapy Manufacturing

Rethinking Cell Engineering for Cell Therapy Manufacturing

Todd Sulchek, Ph.D

CellFE

PAO-11-23-CL-03Dec 13, 2023
Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models
Sustainable Clinical Trials

Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models

Michael J. Cohen

PPD, part of Thermo Fisher Scientific

PAO-12-23-CL-05Dec 13, 2023
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
Process Chemistry

Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation

Jean-Francois Vincent-Rocan, Ph.D.

BIOVECTRA

PAO-12-23-CL-02Dec 13, 2023
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Supply Chain

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma

TriRx Pharmaceutical Services

PTV-12-23-CL-02Dec 12, 2023
Designing A Recipe for Stem Cell Therapy Success
Stem Cell Therapy

Designing A Recipe for Stem Cell Therapy Success

Ben Josey, Ph.D.; Robert Padilla

Corning Life Sciences

PTV-12-23-CL-01Dec 12, 2023
Scaling Cell and Gene Therapy Processes from R&D to Production
Cell and Gene Therapy

Scaling Cell and Gene Therapy Processes from R&D to Production

Shawn Bates; Antonio Fernandez-Perez, Ph.D.

Corning Life Sciences

PAO-12-23-CL-03Dec 12, 2023
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
CDMO Selection

Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)

Scorpius BioManufacturing

PAO-11-23-CL-04Dec 08, 2023
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
Cell Culture Media

Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients

Chris Wiedel

Nu-Tek BioSciences

PAO-10-23-CL-01Dec 06, 2023
Vetter Pharma International GmbH

Vetter joins Science Based Targets Initiative

Vetter Pharma International GmbH

PR-M12-23-01Dec 05, 2023
Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies
Viral Vectors

Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies

Jimmy Vanhove

Viralgen Vector Core

PAO-11-23-CL-02Nov 28, 2023
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
Antibody-Drug Conjugates

Reducing ADC Development Timelines with Integrated Development and Manufacturing Services

Thomas Rohrer

Samsung Biologics

PAO-11-23-CL-01Nov 13, 2023
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

PAO-10-23-CL-07Nov 09, 2023
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
Biotherapeutics

Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO

John R. Mosack

Tanvex CDMO

PAO-10-23-CL-05Nov 07, 2023
1 / 2